{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T11:05:43Z","timestamp":1771326343269,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T00:00:00Z","timestamp":1764979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-025-00515-2","type":"journal-article","created":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T06:47:06Z","timestamp":1765003626000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pathogenic CDKN2A germline variants are rare in a cohort of unselected pancreatic cancer patients from Pakistan"],"prefix":"10.1007","volume":"25","author":[{"given":"Shumaila","family":"Arif","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noor","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humaira","family":"Naeemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7684-3122","authenticated-orcid":false,"given":"Muhammad Usman","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,6]]},"reference":[{"key":"515_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"515_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14740\/wjon1166","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Gaduputi V (2019) Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol 10:10\u201327. https:\/\/doi.org\/10.14740\/wjon1166","journal-title":"World J Oncol"},{"key":"515_CR3","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.Can-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM (2014) Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 74:2913\u20132921. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-0155","journal-title":"Cancer Res"},{"key":"515_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"515_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14102453","author":"N Devico Marciano","year":"2022","unstructured":"Devico Marciano N, Kroening G, Dayyani F, Zell JA, Lee FC, Cho M, Valerin JG (2022) BRCA-mutated pancreatic cancer: from discovery to novel treatment paradigms. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers14102453","journal-title":"Cancers (Basel)"},{"key":"515_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031205","author":"A Kasuga","year":"2022","unstructured":"Kasuga A, Okamoto T, Udagawa S, Mori C, Mie T, Furukawa T, Yamada Y, Takeda T, Matsuyama M, Sasaki T, Ozaka M, Ueki A, Sasahira N (2022) Molecular features and clinical management of hereditary pancreatic cancer syndromes and familial pancreatic cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23031205","journal-title":"Int J Mol Sci"},{"key":"515_CR7","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/368753a0","volume":"368","author":"T Nobori","year":"1994","unstructured":"Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368:753\u2013756. https:\/\/doi.org\/10.1038\/368753a0","journal-title":"Nature"},{"key":"515_CR8","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1001\/jama.2018.6228","volume":"319","author":"C Hu","year":"2018","unstructured":"Hu C, Hart SN, Polley EC, Gnanaolivu R, Shimelis H, Lee KY, Lilyquist J, Na J, Moore R, Antwi SO, Bamlet WR, Chaffee KG, DiCarlo J, Wu Z, Samara R, Kasi PM, McWilliams RR, Petersen GM, Couch FJ (2018) Association between inherited germline mutations in cancer predisposition genes and risk of pancreatic cancer. JAMA 319:2401\u20132409. https:\/\/doi.org\/10.1001\/jama.2018.6228","journal-title":"JAMA"},{"key":"515_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/366704a0","volume":"366","author":"M Serrano","year":"1993","unstructured":"Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of Cyclin D\/CDK4. Nature 366:704\u2013707. https:\/\/doi.org\/10.1038\/366704a0","journal-title":"Nature"},{"key":"515_CR10","first-page":"2995","volume":"55","author":"L Mao","year":"1995","unstructured":"Mao L, Merlo A, Bedi G, Shapiro GI, Edwards CD, Rollins BJ, Sidransky D (1995) A novel p16INK4A transcript. Cancer Res 55:2995\u20132997","journal-title":"Cancer Res"},{"key":"515_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/ejhg.2010.198","volume":"19","author":"RR McWilliams","year":"2011","unstructured":"McWilliams RR, Wieben ED, Rabe KG, Pedersen KS, Wu Y, Sicotte H, Petersen GM (2011) Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling. Eur J Hum Genet 19:472\u2013478. https:\/\/doi.org\/10.1038\/ejhg.2010.198","journal-title":"Eur J Hum Genet"},{"key":"515_CR12","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1136\/jmedgenet-2011-100281","volume":"49","author":"P Ghiorzo","year":"2012","unstructured":"Ghiorzo P, Fornarini G, Sciallero S, Battistuzzi L, Belli F, Bernard L, Bonelli L, Borgonovo G, Bruno W, De Cian F, Decensi A, Filauro M, Faravelli F, Gozza A, Gargiulo S, Mariette F, Nasti S, Pastorino L, Queirolo P, Savarino V, Varesco L, Scarr\u00e0 GB (2012) CDKN2A is the main susceptibility gene in Italian pancreatic cancer families. J Med Genet 49:164\u2013170. https:\/\/doi.org\/10.1136\/jmedgenet-2011-100281","journal-title":"J Med Genet"},{"key":"515_CR13","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/gim.2014.153","volume":"17","author":"DB Zhen","year":"2015","unstructured":"Zhen DB, Rabe KG, Gallinger S, Syngal S, Schwartz AG, Goggins MG, Hruban RH, Cote ML, McWilliams RR, Roberts NJ, Cannon-Albright LA, Li D, Moyes K, Wenstrup RJ, Hartman AR, Seminara D, Klein AP, Petersen GM (2015) BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genet Med 17:569\u2013577 https:\/\/doi.org\/10.1038\/gim.2014.153","journal-title":"Genet Med"},{"key":"515_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/gim.2017.85","volume":"20","author":"KG Chaffee","year":"2018","unstructured":"Chaffee KG, Oberg AL, McWilliams RR, Majithia N, Allen BA, Kidd J, Singh N, Hartman AR, Wenstrup RJ, Petersen GM (2018) Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history. Genet Med 20:119\u2013127. https:\/\/doi.org\/10.1038\/gim.2017.85","journal-title":"Genet Med"},{"key":"515_CR15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41436-018-0009-5","volume":"21","author":"MB Yurgelun","year":"2019","unstructured":"Yurgelun MB, Chittenden AB, Morales-Oyarvide V, Rubinson DA, Dunne RF, Kozak MM, Qian ZR, Welch MW, Brais LK, Da Silva A, Bui JL, Yuan C, Li T, Li W, Masuda A, Gu M, Bullock AJ, Chang DT, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Thorner AR, Ducar MD, Wollison BM, Khalaf N, Perez K, Syngal S, Aguirre AJ, Hahn WC, Meyerson ML, Fuchs CS, Ogino S, Hornick JL, Hezel AF, Koong AC, Nowak JA, Wolpin BM (2019) Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer. Genet Med 21:213\u2013223. https:\/\/doi.org\/10.1038\/s41436-018-0009-5","journal-title":"Genet Med"},{"key":"515_CR16","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1038\/s41467-025-57520-3","volume":"16","author":"X Yin","year":"2025","unstructured":"Yin X, Shen H, Wang H, Wang Q, Zhang S, Zhang C, Jia Q, Guo S, Xu X, Zhang W, Li B, Shi X, Gao S, Shi M, Zhao X, Wang S, Han J, Zhang G, Li Y, Li P, Jing W, Song B, Zheng K, Li G, Zhang Y, Jiang H, Wu C, Song Z, Niu G, Zhang Q, Guo J, Sun Z, Han F, Li Y, Gao D, Jin H, Yang H, Li J, Jin G (2025) Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients. Nat Commun 16:2214. https:\/\/doi.org\/10.1038\/s41467-025-57520-3","journal-title":"Nat Commun"},{"key":"515_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12964-025-02281-1","volume":"23","author":"Y Jiang","year":"2025","unstructured":"Jiang Y, Li D, Liu Y, Qin J, Chen H, Zhang J, Gu Y, Shen B, Jin J (2025) Prevalence and clinical relavance of germline mutations in Chinese patients with pancreatic cancer. Cell Commun Signal 23:300. https:\/\/doi.org\/10.1186\/s12964-025-02281-1","journal-title":"Cell Commun Signal"},{"key":"515_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13053-024-00283-7","volume":"22","author":"Y Kiyozumi","year":"2024","unstructured":"Kiyozumi Y, Matsubayashi H, Todaka A, Ashida R, Nishimura S, Kado N, Higashigawa S, Harada R, Ishihara E, Horiuchi Y, Honda G, Kenmotsu H, Serizawa M, Urakami K (2024) Two Japanese families with Familial pancreatic cancer with suspected pathogenic variants of CDKN2A: a case report. Hered Cancer Clin Pract 22:11. https:\/\/doi.org\/10.1186\/s13053-024-00283-7","journal-title":"Hered Cancer Clin Pract"},{"key":"515_CR19","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1016\/j.hpb.2022.09.003","volume":"24","author":"N Muhammad","year":"2022","unstructured":"Muhammad N, Sadaqat R, Naeemi H, Masood I, Hassan U, Ijaz B, Hanif F, Syed AA, Yusuf MA, Rashid MU (2022) Contribution of germline PALB2 variants to an unselected and prospectively registered pancreatic cancer patient cohort in Pakistan. HPB (Oxford) 24:2134\u20132144. https:\/\/doi.org\/10.1016\/j.hpb.2022.09.003","journal-title":"HPB (Oxford)"},{"key":"515_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13053-023-00269-x","volume":"21","author":"N Muhammad","year":"2023","unstructured":"Muhammad N, Azeem A, Arif S, Naeemi H, Masood I, Hassan U, Ijaz B, Hanif F, Syed AA, Yusuf MA, Rashid MU (2023) Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan. Hered Cancer Clin Pract 21:22. https:\/\/doi.org\/10.1186\/s13053-023-00269-x","journal-title":"Hered Cancer Clin Pract"},{"key":"515_CR21","doi-asserted-by":"publisher","first-page":"e0141562","DOI":"10.1371\/journal.pone.0141562","volume":"10","author":"MU Rashid","year":"2015","unstructured":"Rashid MU, Muzaffar M, Khan FA, Kabisch M, Muhammad N, Faiz S, Loya A, Hamann U (2015) Association between the BsmI polymorphism in the vitamin D receptor gene and breast cancer risk: results from a Pakistani case-control study. PLoS One 10:e0141562. https:\/\/doi.org\/10.1371\/journal.pone.0141562","journal-title":"PLoS One"},{"key":"515_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"515_CR23","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s11033-021-06964-z","volume":"49","author":"SM Ali","year":"2022","unstructured":"Ali SM, Adnan Y, Ahmad Z, Farooqui HA, Chawla T, Ali SMA (2022) Genetic landscape of pancreatic adenocarcinoma patients: a pilot study from Pakistan. Mol Biol Rep 49:1341\u20131350. https:\/\/doi.org\/10.1007\/s11033-021-06964-z","journal-title":"Mol Biol Rep"},{"key":"515_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1266\/ggs.18-00053","volume":"94","author":"R Khan","year":"2019","unstructured":"Khan R, Aftab A, Tabassum S, Hussain HMJ, Hameed A, Mahmood H, Munir F, Bukhari I (2019) Identification of CDKN2A variants in breast cancer patients in Pakistan. Genes Genet Syst 94:117\u2013122. https:\/\/doi.org\/10.1266\/ggs.18-00053","journal-title":"Genes Genet Syst"},{"key":"515_CR25","doi-asserted-by":"publisher","first-page":"e2148721","DOI":"10.1001\/jamanetworkopen.2021.48721","volume":"5","author":"L Yin","year":"2022","unstructured":"Yin L, Wei J, Lu Z, Huang S, Gao H, Chen J, Guo F, Tu M, Xiao B, Xi C, Zhang K, Li Q, Wu J, Gao W, Jiang K, Yu J, Miao Y (2022) Prevalence of germline sequence variations among patients with pancreatic cancer in China. JAMA Netw Open 5:e2148721. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.48721","journal-title":"JAMA Netw Open"},{"key":"515_CR26","doi-asserted-by":"publisher","first-page":"e652","DOI":"10.1097\/sla.0000000000004213","volume":"275","author":"E Takai","year":"2022","unstructured":"Takai E, Nakamura H, Chiku S, Kubo E, Ohmoto A, Totoki Y, Shibata T, Higuchi R, Yamamoto M, Furuse J, Shimizu K, Takahashi H, Morizane C, Furukawa T, Yachida S (2022) Whole-exome sequencing reveals new potential susceptibility genes for Japanese familial pancreatic cancer. Ann Surg 275:e652\u2013e658. https:\/\/doi.org\/10.1097\/sla.0000000000004213","journal-title":"Ann Surg"},{"key":"515_CR27","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10689-010-9329-6","volume":"9","author":"EP Slater","year":"2010","unstructured":"Slater EP, Langer P, Fendrich V, Habbe N, Chaloupka B, Matth\u00e4i E, Sina M, Hahn SA, Bartsch DK (2010) Prevalence of BRCA2 and CDKN2a mutations in German familial pancreatic cancer families. Fam Cancer 9:335\u2013343. https:\/\/doi.org\/10.1007\/s10689-010-9329-6","journal-title":"Fam Cancer"},{"key":"515_CR28","first-page":"409","volume":"60","author":"G Lal","year":"2000","unstructured":"Lal G, Liu G, Schmocker B, Kaurah P, Ozcelik H, Narod SA, Redston M, Gallinger S (2000) Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations. Cancer Res 60:409\u2013416","journal-title":"Cancer Res"},{"key":"515_CR29","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrg3051","volume":"12","author":"ZE Sauna","year":"2011","unstructured":"Sauna ZE, Kimchi-Sarfaty C (2011) Understanding the contribution of synonymous mutations to human disease. Nat Rev Genet 12:683\u2013691. https:\/\/doi.org\/10.1038\/nrg3051","journal-title":"Nat Rev Genet"},{"key":"515_CR30","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jnci\/djac090","volume":"114","author":"NM Kaissarian","year":"2022","unstructured":"Kaissarian NM, Meyer D, Kimchi-Sarfaty C (2022) Synonymous variants: necessary nuance in our understanding of cancer drivers and treatment outcomes. J Natl Cancer Inst 114:1072\u20131094. https:\/\/doi.org\/10.1093\/jnci\/djac090","journal-title":"J Natl Cancer Inst"},{"key":"515_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab023","author":"JBS Gaither","year":"2021","unstructured":"Gaither JBS, Lammi GE, Li JL, Gordon DM, Kuck HC, Kelly BJ, Fitch JR, White P (2021) Synonymous variants that disrupt messenger RNA structure are significantly constrained in the human population. Gigascience. https:\/\/doi.org\/10.1093\/gigascience\/giab023","journal-title":"Gigascience"},{"key":"515_CR32","doi-asserted-by":"publisher","DOI":"10.1590\/1678-4685-gmb-2023-0125","volume":"46","author":"AC Mello","year":"2024","unstructured":"Mello AC, Leao D, Dias L, Colombelli F, Recamonde-Mendoza M, Turchetto-Zolet AC, Matte U (2024) Broken silence: 22,841 predicted deleterious synonymous variants identified in the human exome through computational analysis. Genet Mol Biol 46. https:\/\/doi.org\/10.1590\/1678-4685-gmb-2023-0125","journal-title":"Genet Mol Biol"},{"key":"515_CR33","doi-asserted-by":"publisher","first-page":"7553","DOI":"10.1038\/ncomms8553","volume":"6","author":"H Xu","year":"2015","unstructured":"Xu H, Zhang H, Yang W, Yadav R, Morrison AC, Qian M, Devidas M, Liu Y, Perez-Andreu V, Zhao X, Gastier-Foster JM, Lupo PJ, Neale G, Raetz E, Larsen E, Bowman WP, Carroll WL, Winick N, Williams R, Hansen T, Holm JC, Mardis E, Fulton R, Pui CH, Zhang J, Mullighan CG, Evans WE, Hunger SP, Gupta R, Schmiegelow K, Loh ML, Relling MV, Yang JJ (2015) Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children. Nat Commun 6:7553. https:\/\/doi.org\/10.1038\/ncomms8553","journal-title":"Nat Commun"},{"key":"515_CR34","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/humu.21641","volume":"33","author":"J Gong","year":"2012","unstructured":"Gong J, Tong Y, Zhang HM, Wang K, Hu T, Shan G, Sun J, Guo AY (2012) Genome-wide identification of SNPs in MicroRNA genes and the SNP effects on MicroRNA target binding and biogenesis. Hum Mutat 33:254\u2013263. https:\/\/doi.org\/10.1002\/humu.21641","journal-title":"Hum Mutat"},{"key":"515_CR35","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1158\/0008-5472.835.65.3","volume":"65","author":"T Debniak","year":"2005","unstructured":"Debniak T, Scott RJ, Huzarski T, Byrski T, Rozmiarek A, Debniak B, Za\u0142uga E, Maleszka R, K\u0142adny J, G\u00f3rski B, Cybulski C, Gronwald J, Kurzawski G, Lubinski J (2005) CDKN2A common variants and their association with melanoma risk: a population-based study. Cancer Res 65:835\u2013839","journal-title":"Cancer Res"},{"key":"515_CR36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.14715\/cmb\/2017.63.3.8","volume":"63","author":"Y Dong","year":"2017","unstructured":"Dong Y, Wang X, Yang YW, Liu YJ (2017) The effects of CDKN2A rs3731249, rs11515, and rs3088440 polymorphisms on cancer risk. Cell Mol Biol (Noisy-le-grand) 63:40\u201344. https:\/\/doi.org\/10.14715\/cmb\/2017.63.3.8","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"515_CR37","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/humu.20931","volume":"30","author":"V Polakova","year":"2009","unstructured":"Polakova V, Pardini B, Naccarati A, Landi S, Slyskova J, Novotny J, Vodickova L, Bermejo JL, Hanova M, Smerhovsky Z, Tulupova E, Kumar R, Hemminki K, Vodicka P (2009) Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic. Hum Mutat 30:661\u2013668. https:\/\/doi.org\/10.1002\/humu.20931","journal-title":"Hum Mutat"},{"key":"515_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1089\/dna.2007.0650","volume":"27","author":"D Landi","year":"2008","unstructured":"Landi D, Gemignani F, Barale R, Landi S (2008) A catalog of polymorphisms falling in microRNA-binding regions of cancer genes. DNA Cell Biol 27:35\u201343. https:\/\/doi.org\/10.1089\/dna.2007.0650","journal-title":"DNA Cell Biol"},{"key":"515_CR39","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1093\/carcin\/bgu207","volume":"35","author":"MF Buas","year":"2014","unstructured":"Buas MF, Levine DM, Makar KW, Utsugi H, Onstad L, Li X, Galipeau PC, Shaheen NJ, Hardie LJ, Romero Y, Bernstein L, Gammon MD, Casson AG, Bird NC, Risch HA, Ye W, Liu G, Corley DA, Blount PL, Fitzgerald RC, Whiteman DC, Wu AH, Reid BJ, Vaughan TL (2014) Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. Carcinogenesis 35:2740\u20132747. https:\/\/doi.org\/10.1093\/carcin\/bgu207","journal-title":"Carcinogenesis"},{"key":"515_CR40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1146\/annurev-genet-120116-024704","volume":"51","author":"C Mayr","year":"2017","unstructured":"Mayr C (2017) Regulation by 3\u2019-untranslated regions. Annu Rev Genet 51:171\u2013194. https:\/\/doi.org\/10.1146\/annurev-genet-120116-024704","journal-title":"Annu Rev Genet"},{"key":"515_CR41","doi-asserted-by":"publisher","first-page":"e1008977","DOI":"10.1371\/journal.pgen.1008977","volume":"16","author":"ED Shulman","year":"2020","unstructured":"Shulman ED, Elkon R (2020) Systematic identification of functional SNPs interrupting 3\u2019UTR polyadenylation signals. PLoS Genet 16:e1008977. https:\/\/doi.org\/10.1371\/journal.pgen.1008977","journal-title":"PLoS Genet"},{"key":"515_CR42","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/s0002-9440(10)64174-0","volume":"161","author":"O Straume","year":"2002","unstructured":"Straume O, Smeds J, Kumar R, Hemminki K, Akslen LA (2002) Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase. Am J Pathol 161:229\u2013237. https:\/\/doi.org\/10.1016\/s0002-9440(10)64174-0","journal-title":"Am J Pathol"},{"key":"515_CR43","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.tcb.2022.10.001","volume":"33","author":"JJ Chan","year":"2023","unstructured":"Chan JJ, Tabatabaeian H, Tay Y (2023) 3\u2019UTR heterogeneity and cancer progression. Trends Cell Biol 33:568\u2013582. https:\/\/doi.org\/10.1016\/j.tcb.2022.10.001","journal-title":"Trends Cell Biol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00515-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-025-00515-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-025-00515-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T06:47:07Z","timestamp":1765003627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-025-00515-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,6]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1007\/s10689-025-00515-2","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,6]]},"assertion":[{"value":"29 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained from all participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study was approved by the Institutional Review Board (IRB) of Shaukat Khanum Memorial Cancer Hospital and Research Centre (IRB approval numbers IRB-16-14, Date: December 16, 2016).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"2"}}